Medicure (Canada)

Recent papers from Medicure (Canada)

1. Illness severity modifies the association between sepsis and survival in critically ill patients with acute kidney injuryClinical and Experimental Nephrology · 2026
2. Pyridoxal-5′-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptorsCanadian Journal of Physiology and Pharmacology · 2013
3. Pharmacokinetic modeling of the high-dose bolus regimen of tirofiban in patients with severe renal impairmentCoronary Artery Disease · 2012
4. Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated UropathogensAntimicrobial Agents and Chemotherapy · 2006
5. MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injuryExpert Opinion on Investigational Drugs · 2005
6. Design and Synthesis of Novel Pyridoxine 5‘-Phosphonates as Potential Antiischemic AgentsJournal of Medicinal Chemistry · 2003